BREAKING: We’re launching an innovative COVID-19 rapid antigen test and mobile app. BinaxNOW is fast and reliable for frequent mass testing, and results pair with the NAVICA app’s digital pass to help get back to life with a bit more confidence. https://t.co/LKefDGEx3f pic.twitter.com/SL7SWdrj9t
— Abbott (@AbbottNews) August 26, 2020
A new study published in the Journal of Neurotrauma shows that a rapid blood test for concussions we’re developing is a reliable indicator of traumatic brain injuries. https://t.co/0tVhjcq4Ux pic.twitter.com/OSv8XpoJ7G
— Abbott (@AbbottNews) September 23, 2020
We’re proud to be named to @FortuneMagazine’s #ChangeTheWorld list for expanding access to care in Rwanda, and work to advance COVID-19 testing.
Learn more: https://t.co/TwAxofeAy3 #SharedValue pic.twitter.com/D8xQTgs3xq
— Abbott (@AbbottNews) September 22, 2020
Heart tech that helps people live healthier. Our fourth-generation MitraClip G4 device received CE Mark, offering an enhanced approach for mitral valve repair in the EU: https://t.co/vuEEwBVIht
Important Safety Info: https://t.co/yQ2GUvJVHM pic.twitter.com/GTjBS39QBy
— Abbott (@AbbottNews) September 22, 2020
Backed by our pioneering track record of innovation, medical firsts, and clinical credibility, Libre Sense Glucose Sport Biosensor—when used with a compatible partner app—allows athletes to correlate their nutrition choices to their athletic performance: https://t.co/hSUFkUPJuk pic.twitter.com/lzYvWEP3Is
— Abbott (@AbbottNews) September 22, 2020
NEWS: Our next-generation MitraClip G4 received CE Mark and is now approved in the EU to treat patients with mitral regurgitation: https://t.co/vuEEwBVIht
Important Safety Info: https://t.co/yQ2GUvJVHM pic.twitter.com/UCEGkKUd57
— Abbott (@AbbottNews) September 21, 2020
One size does not fit all, especially for cardiovascular diseases.
Read our Beyond Intervention white paper findings on how technology could create tailored, patient-centric care: https://t.co/b96X3cLCzv pic.twitter.com/AU0CseP0MN
— Abbott (@AbbottNews) September 18, 2020
Today we declared a quarterly #dividend of 36 cents per share. As a member of the S&P 500 Dividend Aristocrats Index, we’ve increased our dividend payout for 48 consecutive years: https://t.co/xAxPweYdZZ #DividendAristocrat pic.twitter.com/zN6ooNJT7M
— Abbott (@AbbottNews) September 17, 2020
Proud to be on this list for the 20th-straight time.
Thanks to all of our working parents for showing perseverance and passion this year. https://t.co/zbsAmPAE4y
— Abbott (@AbbottNews) September 15, 2020
Balancing family and career and times of uncertainty. We’re thankful for the perseverance and commitment of our working parents who enable us to continue to deliver our life-changing health technologies when they’re needed most. https://t.co/xCaWDNThko pic.twitter.com/cGlFdSGlyJ
— Abbott (@AbbottNews) September 15, 2020
60% of people across Africa live in rural areas with limited access to care.
We're helping @RwandaHealth and @SFHRwanda to bring more comprehensive care and testing closer to home through the power of innovation: https://t.co/x50Xe1Ask5 #SharedValue pic.twitter.com/8V8Gl5bnCt
— Abbott (@AbbottNews) September 14, 2020
Sustainability is central to our purpose of helping people live fully.
Find out how in our global sustainability report: https://t.co/uWFD1Okbb1
— Abbott (@AbbottNews) September 8, 2020
ICYMI: Our Freestyle Libre 2 system is now covered by Medicare. Meeting the highest level of accuracy standard*, every minute. https://t.co/Na9CZGhgtp
Important safety info: https://t.co/w2niXXYyAj
*Based on FDA iCGM special controls pic.twitter.com/zhTxJ0PbJF— Abbott (@AbbottNews) September 4, 2020
First enrollments have begun for the first clinical trial in the U.S. to evaluate a fully resorbable device to treat blocked arteries in people with critical limb ischemia. https://t.co/01JDZe668B pic.twitter.com/Vtd0tRggt4
— Abbott (@AbbottNews) September 4, 2020
ANNOUNCEMENT: The first patient has been enrolled in a clinical trial to evaluate the new Esprit BTK drug-eluting resorbable scaffold: https://t.co/01JDZe668B
*Investigational device only in the U.S. pic.twitter.com/SME8Ptz31H
— Abbott (@AbbottNews) September 3, 2020
Now covered by Medicare: Our FreeStyle Libre 2 system, the only iCGM that measures glucose levels every minute, so people can make the right decisions at the right time about their health: https://t.co/Na9CZGhgtp
Important safety info: https://t.co/w2niXXYyAj pic.twitter.com/KcI8RJwrqT
— Abbott (@AbbottNews) September 1, 2020
Bringing accessible diagnostics testing to more people in more places. Our BinaxNOW COVID-19 Ag Card is a rapid antigen test with no equipment required that delivers results in 15 minutes: https://t.co/r0vSNE20ul pic.twitter.com/xmR6uNKHRd
— Abbott (@AbbottNews) August 28, 2020
To fight COVID-19, diagnostics are a powerful tool to help us navigate daily life. Our BinaxNOW rapid antigen test and NAVICA mobile app pair fast, reliable test results with a digital pass to help facilitate entry into organizations like work, schools: https://t.co/LW8LjdvUby pic.twitter.com/OweknZ5QEy
— Abbott (@AbbottNews) August 27, 2020
"We intentionally designed the BinaxNOW test and NAVICA app so we could offer a comprehensive testing solution to help Americans feel more confident about their health and lives." – Robert B. Ford, president and chief executive officer, Abbott. https://t.co/gn5PoryN1o
— Abbott (@AbbottNews) August 27, 2020
Addressing the unmet needs of babies with congenital heart defects: our Masters 15mm valve and Amplatzer Piccolo. We’re honored to be recognized by @TCBmag for manufacturing excellence.
Important safety info: https://t.co/dvqDD0xs0A & https://t.co/poUDFD30q0 pic.twitter.com/eivjAhut7h
— Abbott (@AbbottNews) August 20, 2020
True. Authentic. Real.
That’s how we want all 107,000 of our employees to feel at our workplaces around the world. We’re proud our diversity and inclusion efforts have been recognized by @_workingmother_ #DBPInclusionIndex: https://t.co/gN7aopRaMI pic.twitter.com/Iqbti8I8cq
— Abbott (@AbbottNews) August 18, 2020
Here’s why @RomanchukDaniel trusts our therapeutic nutrition drink, Juven, to support wound healing while pushing over 100 miles a week. pic.twitter.com/yA8nLfF4X6
— Abbott (@AbbottNews) August 17, 2020
In true champion form, @RomanchukDaniel is always ready to adapt, even during COVID-19.
In the midst of a pandemic, he organized a virtual marathon that brought together over 60 athletes from a dozen countries. Here’s his story: https://t.co/Hmeoovdq5T pic.twitter.com/58Xuf0Ryr5
— Abbott (@AbbottNews) August 13, 2020
People recovering from serious illnesses like COVID-19 can struggle to regain strength, energy and immune health.
Here’s 5 things you can do to support your muscle and overall health via @usnews: https://t.co/iU4hwmxTPZ
— Abbott (@AbbottNews) August 14, 2020
The role that nutrition plays in supporting would healing can sometimes be overlooked.
Here’s how Juven, a therapeutic nutrition drink, can help: https://t.co/nyIQwES1O8
— Abbott (@AbbottNews) August 12, 2020
Advancing emergency medicine in Africa when it’s needed most.
We’re working with @afemafrica to provide 8 months of virtual trainings on COVID-19 care to 2,000 frontline providers in Africa.
Here’s how: https://t.co/mVrhm9hT0Y pic.twitter.com/OKhulyP9OV
— Abbott (@AbbottNews) August 7, 2020
Our innovative spirit drives us to create health technologies that help people around the world live their best lives. Thanks for recognizing us @FastCompany #FCBestWorkplaces https://t.co/6lkaxD8JSc
— Abbott (@AbbottNews) July 29, 2020
Smartphones. They’ve seamlessly integrated into our daily lives.
We’re using that integration to take an innovative approach to deep brain stimulation: https://t.co/XYtnr7XhzR
Imp safety info: https://t.co/s6bEuReMwR pic.twitter.com/ds5DyAHVzf
— Abbott (@AbbottNews) July 28, 2020
Life-changing tests and diagnostics tools that enable smarter, faster decisions to better manage your health. Thank you @SelectScience for recognizing us as Clinical Company of the Year. https://t.co/yQ7IZG5123
— Abbott (@AbbottNews) July 23, 2020
COVID-19 infection: past or present? There are different types of tests for each. pic.twitter.com/xZHJaSSrCT
— Abbott (@AbbottNews) July 23, 2020
Community health centers are on the front lines of the COVID-19 fight in vulnerable communities. Thanks to @DirectRelief for the partnership to help advance COVID-19 testing. https://t.co/hblaRPOz5v
— Abbott (@AbbottNews) July 21, 2020
We exceeded expectations in Q2, topping analyst estimates for EPS and sales growth: https://t.co/K2ULlDBug7 $ABT #earnings pic.twitter.com/XNz9ez2ahV
— Abbott (@AbbottNews) July 16, 2020
How do our coronavirus tests differ?
Learn more: https://t.co/sAf2CQayYY pic.twitter.com/uiy8efZOJu
— Abbott (@AbbottNews) July 13, 2020
Millions of people served globally, every day.
Here’s how our quality and assurance teams in our nutrition business utilize resilience to deliver needed products to families who depend on them, especially during a pandemic: https://t.co/onrjYn8G2C
— Abbott (@AbbottNews) July 13, 2020
Wondering if that “flu” or really bad cold from the winter was COVID-19? Find out for sure. Get an antibody test. Learn how here: https://t.co/vuRVCRotHO pic.twitter.com/vFRDq8zCG1
— Abbott (@AbbottNews) July 9, 2020
Our interns are our future leaders.
That’s why it’s important for us to make sure they’re having valuable and engaging experiences this summer. Thanks @SHRMHRNews for highlighting our efforts. https://t.co/fOeBP61osV
— Abbott (@AbbottNews) July 9, 2020
Blood and plasma is needed now more than ever. Your donation could save the lives of up to 3 people. #BETHE1Donor https://t.co/9EvPnOdwzE pic.twitter.com/X5wzRmi4Tr
— Abbott (@AbbottNews) July 6, 2020
Caring. It’s in our DNA. It’s seen in the efforts our team members make, both at work and in their communities, like our colleague here in India who’s sewing masks and providing essential products to families in his area. pic.twitter.com/9AQCnVDKzu
— Abbott (@AbbottNews) July 1, 2020
No one knows how long this pandemic will last, but we do know that we’re committed to help fight it until the end. Our colleagues at this diagnostics site are working around the clock to deliver the critical tests needed for our m2000 laboratory system. https://t.co/euNbOD9bnI pic.twitter.com/NIKtURUGFr
— Abbott (@AbbottNews) June 30, 2020
By combining our glucose sensing technology with @TandemDiabetes proven insulin delivery systems, we will be able to create a cohesive ecosystem for people with diabetes that can fit easily into their daily lives: https://t.co/fgWVLyN8FE pic.twitter.com/kidtNakuTV
— Abbott (@AbbottNews) June 29, 2020
ANNOUNCEMENT: New research finds our optical coherence tomography imaging changed treatment decisions in 88% of artery blockages. Learn more: https://t.co/YguTyWpeH1 pic.twitter.com/3dHUbTyvHO
— Abbott (@AbbottNews) June 26, 2020
NEWS: Late-breaking data highlight impact of our minimally invasive therapies for people with structural heart diseases https://t.co/2dxqBHZ6i8 pic.twitter.com/wZDI1HoqZD
— Abbott (@AbbottNews) June 25, 2020
The research community is trying to better understand what antibody responses to COVID-19 mean. @Time covers what is known to date: https://t.co/yaDF4M95pB
— Abbott (@AbbottNews) June 24, 2020
COVID-19 antibody questions? Get answers: https://t.co/JlrD1RCq8G pic.twitter.com/3YgcQyd0g5
— Abbott (@AbbottNews) June 18, 2020
A sustainable future depends on environmental, social, and governance transparency and leadership.
We're honored to be one of the few on this list for 12 consecutive years. #100BestCC https://t.co/itiGdj2WOJ
— Abbott (@AbbottNews) June 17, 2020
Blood and plasma are needed more than ever. See how you could save lives: https://t.co/3F57uwvE2O #BETHE1Donor pic.twitter.com/Qi6PSbhQwr
— Abbott (@AbbottNews) June 14, 2020
We depend on frontline health workers providing critical care. And they can depend on us to do everything we can to fight this evolving threat. That’s why our colleagues here are working tirelessly to produce millions of our antibody tests each month. pic.twitter.com/Tdaa6wCqxp
— Abbott (@AbbottNews) May 28, 2020
NEWS: We’ve received FDA Emergency Use Authorization for our COVID-19 antibody blood test on our Alinity i System.
Data shows reliable results with 99.6% specificity and 100% sensitivity for patients tested 14 days after symptoms began: https://t.co/lN1DZihA4K pic.twitter.com/fYI8DdoFm9
— Abbott (@AbbottNews) May 11, 2020
We’re tackling COVID-19 head-on.
Recently, we announced our third COVID-19 test, an antibody test that can help determine if a person has had the novel coronavirus and whether they have developed antibodies: https://t.co/1GpMRKakpz pic.twitter.com/tL1bccE76x
— Abbott (@AbbottNews) April 17, 2020
We’re expanding COVID-19 testing options, launching an antibody test that runs on our ARCHITECT i1000SR and i2000SR lab instruments. We’ll start shipping this week and will ship 4 million tests in April, ramping to 20 million in the U.S. per month in June: https://t.co/bdXSrdd0YD pic.twitter.com/kv24A7NW35
— Abbott (@AbbottNews) April 15, 2020
BREAKING: We’re launching a COVID-19 antibody test that can help determine if a person has been previously infected.
We’ll supply 4 million tests in April, ramping up capacity to 20 million in the U.S. per month in June and beyond. Learn more: https://t.co/sxVOVgegMT pic.twitter.com/6xS1LjbaRB
— Abbott (@AbbottNews) April 15, 2020
With the combination of our lab and molecular point-of-care COVID-19 testing capabilities, we will supply about 5 million tests per month: https://t.co/mgOdVzMT3E pic.twitter.com/3oPMaNqkQe
— Abbott (@AbbottNews) March 30, 2020
https://twitter.com/cheddar/status/1299373636323872771
Highlight: “We’re providing a reliable and affordable rapid test at massive scale,” @AbbottGlobal R&D Divisional Vice President Dr. John Hackett says. “This is so portable… and so it allows health care providers to be able to test a lot more people.” Full interview: pic.twitter.com/YYrCK2OP4t
— Yahoo Finance (@YahooFinance) August 27, 2020
Abbott Laboratories new rapid test for the Coronavirus strain Covid-19 should expand much-needed access and help fill in gaps where U. S. testing has been slow and still unavailable months into the pandemic.https://t.co/BZbrFnMluf pic.twitter.com/BOByDOEI9Y
— Forbes Science (@ForbesScience) August 31, 2020
$5 rapid Covid-19 test from Abbott Labs gets emergency FDA approvalhttps://t.co/9JM6clFNuE By @DanielCassady pic.twitter.com/kw07QO4YkK
— Forbes Tech (@ForbesTech) August 27, 2020
Abbott’s rapid COVID-19 test: Here’s how it’s different from the rest https://t.co/TUzAUTsTf0
— Fast Company (@FastCompany) August 27, 2020
The first rapid coronavirus test that doesn't need any special computer equipment to produce results has been approved by the FDA. Its maker reports that it will sell for $5. https://t.co/JlI5ranEaJ pic.twitter.com/EppNfDTt3S
— WebMD (@WebMD) August 27, 2020
FDA authorizes Abbott’s fast $5 COVID-19 test https://t.co/ShGXqlztsz pic.twitter.com/qK789Xkinm
— The Verge (@verge) August 27, 2020
The FDA granted emergency-use authorization to Abbott Laboratories for a $5 rapid-response Covid-19 antigen test https://t.co/rLRXJpYDUl
— The Wall Street Journal (@WSJ) August 26, 2020
The US Food and Drug Administration issued an emergency use authorization to BinaxNOW Covid-19 Ag Card – a rapid antigen test made by Abbott that can detect Covid-19 infection in 15 minutes.
It uses the same type of technology as a flu test. https://t.co/306d6ZxEwo
— CNN (@CNN) August 27, 2020
A 15-minute Covid test that will be priced at just $5 has been granted emergency authorization for use in the U.S. and could ease a major bottleneck https://t.co/5amsOKePuQ
— Bloomberg (@business) August 26, 2020
BREAKING: U.S. Approves Abbott Labs $5 ‘Mass Scale’ Covid-19 Test via @forbes https://t.co/pKYTutRquY
— Bruce Japsen (@brucejapsen) August 26, 2020
@ScottGottliebMD Doc, i think this is the big one.. first large scale test that can make us be able to travel, go to work, test test test without the maddening delay…I am calling it big.. You??? https://t.co/Pml0qXGuyH
— Jim Cramer (@jimcramer) August 26, 2020
Bingo! Abbott with the game-changer–a 15 minute test ready next week!! $5 i think it's the real deal… because it's 98% accurate and it is ready in scale by the millions…Think pregnancy test . Time to travel again?
— Jim Cramer (@jimcramer) August 26, 2020
#WaitJustaMinute, what is antibody testing and why is it important?
Watch as Abbott's principal scientist and #VirusHunter, Mary Rodgers, explain the importance of #antibodytesting and what we've learned so far.https://t.co/CXMOi4EpQh
— The Chicago Council (@ChicagoCouncil) July 13, 2020
https://twitter.com/cheddar/status/1266049375387648000
From a new implant to keep babies' hearts healthy, to fighting malaria, to advancing the careers of underrepresented people in STEM, @AbbottGlobal's range of entries to #FCWorldChangingIdeas made it our selection for World Changing Company of the Year. https://t.co/HwqdoE0TNw
— Fast Company (@FastCompany) April 29, 2020
Breaking: Abbott just announced they have been given emergency use authorization for a rapid antigen test. They say: 15 minutes. 5 dollars. Greater than 95% sensitivity and no machine or lab required, adding they have the ability to make 50 million tests per month by October. pic.twitter.com/Ap7UBAn2UW
— Dr. Sanjay Gupta (@drsanjaygupta) August 26, 2020
Today's Special:
A potential game-changer in COVID-19 testing. Don't miss @megtirrell's exclusive interview with @AbbottNews CEO Robert Ford as they'll discuss the company's $5 rapid test. $ABT pic.twitter.com/xOnFYyyLtc— Power Lunch (@PowerLunch) August 28, 2020
#WomensEqualityDay is not only intended to commemorate the passage of the 19th Amendment in 1920, but to also exemplify women’s hard work and accomplishments throughout the years. Learn how @AbbottNews are diversifying the #FutureOfSTEM with women in #STEM https://t.co/wKGHnOfcmP
— STEMconnector (@STEMconnector) August 26, 2020
There should be #NoCeilings for women who want to help others live their healthiest, fullest lives. That’s why we’re proud to be on the 2020 NAFE list of Top Companies for Executive Women for 12 straight years. #NAFETop https://t.co/vVE5xKgaoP
— Abbott (@AbbottGlobal) March 3, 2020
Is your toddler eating enough of these important nutrients? https://t.co/XI4VKyX5ST pic.twitter.com/oc5gnhjfXZ
— Abbott (@AbbottGlobal) March 3, 2020